Segment Information (Tables)

12 Months Ended

Dec. 31, 2024

Segment Reporting [Abstract]

Schedule of Segment Reporting Information by Segment

Revenue, cost of sales and gross profit for each of our reportable segments were as follows:

	Year Ended December 31,
(in thousands)	2024		2023		2022
Revenue:
Healthcare Solutions	$	189,736	$	213,216	$	260,988
Industrial Solutions	250,385		274,853		277,043
Total revenue	440,121		488,069		538,031
Cost of sales:
Healthcare Solutions	116,237		128,066		162,221
Industrial Solutions	159,706		163,582		161,577
Total cost of sales	275,943		291,648		323,798
Gross profit:
Healthcare Solutions	73,499		85,150		98,767
Industrial Solutions	90,679		111,271		115,466
Total gross profit	164,178		196,421		214,233
Selling, general and administrative	(210,132)		(210,172)		(244,181)
Research and development	(86,479)		(89,466)		(87,071)
Asset impairment charges	(144,967)		(302,787)		—
Foreign exchange gain (loss), net	2,452		(4,825)		(4,424)
Interest income	7,302		19,511		9,352
Interest expense	(2,564)		(3,301)		(2,811)
Other income (loss), net	20,214		32,307		(5,907)
Loss before income taxes	$	(249,996)	$	(362,312)	$	(120,809)

Depreciation and amortization included in the measurement of gross profit by segment were as follows:

	Year Ended December 31,
(in thousands)	2024		2023		2022
Depreciation and amortization:
Healthcare Solutions	$	5,389	$	4,593	$	4,850
Industrial Solutions	$	2,947	$	2,801	$	2,461

Schedule of Long-Lived Assets by Geographical Region

The following table summarizes long-lived assets by geographic region as of December 31, 2024 and 2023:

	December 31,
(in thousands)	2024		2023
United States	$	76,829	$	94,734
Belgium	19,598		21,524
Other foreign entities	14,058		18,783
Total	$	110,485	$	135,041